Introduction {#S5}
============

Recent studies investigating the role of the D~1~ receptor in animal models of cocaine dependence suggest that increased signaling at this receptor may provide a novel treatment approach for this disorder ([@R44]; [@R46]). In animal models of cocaine dependence, the administration of a D~1~ agonist attenuates cocaine-seeking behavior elicited by a priming dose of cocaine in rodents and non-human primates ([@R12]; [@R13]; [@R26]; [@R44]). Similar results have shown that a D~1~ agonist also reduces cue-induced cocaine seeking behavior ([@R2]). In a related study, rats with higher preferred levels of cocaine self-administration were found to be less sensitive to D~1~ mediated inhibition of cocaine-seeking behavior compared to rats with lower levels of cocaine intake ([@R14]). Alternatively, D~1~ antagonists administered directly into the nucleus accumbens have been shown to increase cocaine self-administration in rodents ([@R8]; [@R31]). Together, these data suggest that excessive cocaine self-administration may be associated with a loss of signaling at the D~1~ receptor, and that D~1~ receptor blockade in the nucleus accumbens may increase the risk of relapse.

In line with this theory, it might be expected that cocaine dependence is associated with a decrease in D~1~ receptor availability. However, previous studies in rodents and non-human primates have demonstrated both a decrease ([@R16]; [@R28]; [@R37]) as well as an increase ([@R30]; [@R39]; [@R51]) in striatal D~1~ receptors following chronic exposure to cocaine. In humans, a post-mortem study showed that striatal D~1~ receptor mRNA was unchanged in chronic cocaine abusers, although D~1~ receptor density was not measured ([@R34]). Only one previous study has used PET imaging to measure changes in D~1~ receptor binding associated with cocaine exposure, and this study showed a significant decrease in rodents exposed to cocaine for at least seven days ([@R50]).

In order to investigate the effects of cocaine dependence on D~1~ receptor availability, we used PET and the radiotracer \[^11^C\]NNC 112 in a group of human cocaine dependent (CD) subjects and matched healthy controls (HC). Following the PET scans, the cocaine dependent subjects underwent cocaine self-administration sessions in order to explore the association between D~1~ receptor availability and cocaine seeking behavior. Animal studies have shown that a priming dose of cocaine reinstates cocaine self-administration ([@R26]; [@R44]; [@R47]) and a similar laboratory model has been developed for human subjects ([@R18]; [@R32]). In this model, non-treatment seeking, recently-detoxified cocaine dependent volunteers were given the choice to self-administer cocaine over an alternative reinforcer (money) following a response-independent ("priming") dose of cocaine. The self-administration sessions provide a measure of each subject\'s vulnerability to the reinforcing effects of cocaine, which can then be correlated with D~1~ receptor availability. Our hypotheses were: 1) cocaine dependence would be associated with a decrease in D~1~ receptor availability in the ventral striatum, and; 2) the cocaine dependent subjects with the lowest D~1~ receptor availability in the ventral striatum would be more likely to choose cocaine over an alternative reinforcer in the self-administration sessions.

Materials and Methods {#S6}
=====================

Human Subjects {#S7}
--------------

The study was approved by the Institutional Review Board of the New York State Psychiatric Institute. All subjects provided written informed consent. The cocaine dependent volunteers (CD) were medically healthy, and fulfilled DSM-IV criteria for cocaine dependence, with no other current axis I diagnosis. The CD participants had weekly cocaine use greater than the amount of cocaine used in this study and tested positive for cocaine (urine toxicology) at screening. They were not seeking treatment, but were informed that a referral for treatment was available. CD subjects were required to use alcohol or cannabis less than twice a week and no use of prescription medications or other illicit drugs was permitted in the six months prior to study entry. Seventeen of the CD subjects had been scanned with another radiotracer in a previously reported study ([@R32]). Healthy control subjects (HC) were between the ages of 21 and 45 and had no current or past DSM-IV Axis I disorder. Nicotine dependence was acceptable for both groups.

The CD subjects were admitted to the Irving Center for Clinical Research at the New York Presbyterian Hospital and underwent random urine tests to confirm abstinence. The PET scans were performed following 14 days of abstinence, and the cocaine self-administration sessions were performed 2 to 3 days after the PET scans.

PET scan acquisition {#S8}
--------------------

\[^11^C\]NNC 112 was synthesized as previously described ([@R20]), and injected intravenously over 45 seconds following a transmission scan. Emission data were acquired using the ECAT EXACT HR+ camera in 3D mode for 90 minutes, as previously described ([@R1]). The arterial input was obtained by collecting arterial samples every 10 seconds with an automated sampling system (for the first 2 minutes) followed by manual samples at longer intervals, for a total of 30 samples. Six samples were collected (at 2, 8, 16, 30, 50, and 70 minutes) and further processed by high pressure liquid chromatography (HPLC) to measure the percent of plasma activity representing unmetabolized (parent) \[^11^C\]NNC 112. The measured input function values (C~a~(t), μCi/mL) were analyzed as previously described and used for the kinetic analysis of the regional brain uptake ([@R1]). The clearance of the parent compound (C~L~, L/h) was calculated as the ratio of the injected dose to the area under the curve of the input function. The plasma free fraction (f~P~), was calculated as the ratio of the ultrafiltrate to the total activity concentration as previously described ([@R1]).

PET image analysis {#S9}
------------------

Image analysis was performed in MEDx (Sensor Systems, Inc., Sterling, Virginia) using a region of interest analysis as described previously ([@R1]). Correction for head movement and coregistration of the PET data to the MR were performed using automated image registration (AIR) ([@R53]; [@R54]). The regions of interest (ROIs) were identified on each individual subject\'s MRI, acquired on the GE 1.5 T Signa Advantage system. The ROI\'s included both cortical and subcortical regions. The subcortical regions included the striatum (STR), amygdala (AMY), and hippocampus (HIP). The striatum was divided into the caudate, putamen, and ventral striatum (VST). The caudate and putamen were further subdivided along their rostral-caudal axis using the anterior commissure (AC) to derive the following ROIs: 1) pre-commissural dorsal caudate (preDCA), 2) pre-commissural dorsal putamen (preDPU), 3) the post-commissural caudate (postCA) and 4) the post-commissural putamen (postPU). The striatal ROIs were classified as belonging to the limbic striatum (LST), associative striatum (AST), or sensorimotor striatum (SMST), based on cortical connectivity (for reviews see [@R19]; [@R24]). The LST corresponded to the VST, the AST activity was derived as the spatially weighted average of the activities in the preDCA, preDPU and postCA, and the SMST corresponded to the postPU. Details of the anatomical criteria and functional classification of the striatum have been described previously ([@R33]). The cortical regions included the dorsolateral prefrontal cortex (DLPFC), medial prefrontal cortex (MPFC), orbitofrontal cortex (OFC), parietal cortex (PC), temporal cortex (TC), occipital cortex (OC), and anterior cingulate cortex (ACC) as described previously ([@R1]). A segmentation procedure was implemented for the cortical regions so that only the voxels classified as gray matter were used to measure the activity distribution ([@R1]). For all bilateral regions, right and left values were averaged.

### PET outcome measures {#S10}

The regional distribution volumes (V~T~, mL of plasma / g of tissue) were derived with a kinetic analysis using the arterial input function as previously described ([@R1]). A one tissue compartment was used in the cerebellum, and a two-tissue compartment in other regions. D~1~ receptor availability was calculated with two outcome measures: \[^11^C\]NNC 112 binding potential (BP~p~, mL/g) and the specific to nonspecific partition coefficient (BP~ND~, unitless) ([@R23]; [@R49]).

BP~p~ and BP~ND~ are defined as: $$BP_{p} = V_{T\, ROI} - V_{T\, CER} = f_{p} \ast \frac{B_{MAX}}{{K_{D}}^{\prime}}\quad\quad BP_{ND} = \frac{V_{T\, ROI} - V_{T\, CER}}{V_{T\, CER}} = f_{ND} \ast \frac{B_{MAX}}{{K_{D}}^{\prime}}$$

V~T~ (mL g^-1^) is the regional tissue distribution volume for the ROIs and cerebellum (CER), f~ND~ is the free fraction in the nonspecific distribution volume of the brain, f~P~ is the free fraction in the plasma, B~max~ is the concentration of D~1~ receptors (nmoles per g of tissue), and K~D~′ is the in vivo equilibrium dissociation constant of the radiotracer in the presence of dopamine ([@R49]). V~TCER~ was measured for each subject in order to ensure that there was no difference in non-specific binding between the two groups. The contribution of total plasma activity to the regional time activity data was calculated assuming a fixed 5% blood volume in the regions of interest ([@R36]). It should be note that \[^11^C\]NNC 112 labels both the D~1~ and D~5~ receptors, and the term D~1~ is used to denote both receptors.

Self-administration sessions {#S11}
----------------------------

The cocaine dependent subjects underwent two types of cocaine self-administration sessions: sample sessions and choice sessions. In the sample sessions, the subjects self-administered a single dose of smoked cocaine (0, 6, or 12 mg of cocaine, 1 session of each dose per subject). The subjects were asked to rate the subjective effects at baseline, and at 4, 14, 30, and 60 minutes following the dose. The computerized subjective effects battery consisted of visual analog scales (VAS) labeled "not at all" at 0 mm and "extremely" at 100 mm, as previously described ([@R17]). A previous cluster analysis demonstrated that the VAS "good drug effect", "high", and "stimulated" can be grouped into the positive effects cluster ([@R15]). The positive effects cluster was chosen a priori for correlation with D~1~ receptor availability. For each VAS, the area under the curve (AUC) was calculated relative to the baseline score and the positive effects score was derived as the average AUC for the VAS within this cluster.

In the choice sessions, the CD subjects underwent three cocaine self-administration sessions with 0 mg, 6 mg, and 12 mg doses of smoked cocaine presented in counterbalanced order, as previously described ([@R18]; [@R32]). Each session began with a response-independent or "priming" dose of cocaine (0, 6, or 12 mg). Following this dose, subjects were given the choice between the same dose of cocaine or a \$5.00 merchandise voucher redeemable at local stores and paid upon discharge. Subjects were presented with this choice 5 times, spaced 14 minutes apart. Participants were required to press a space bar in order to receive their choice using a progressive ratio (200, 600, 1000, 1400 and 1600 responses required). The outcome measure for the choice sessions was the number of times a given dose of cocaine was chosen over voucher (range 0-5).

Statistical Analysis {#S12}
--------------------

Group demographic comparisons were performed with unpaired t tests. Differences in \[^11^C\]NNC 112 BP~p~ and BP~ND~ between the CD and HC were analyzed by multivariate analysis of variance (MANOVA). The vector of regional BP~p~ and BP~ND~ measurements was the multivariate statistic. Post-hoc tests, when indicated, were performed by region, controlling the false discovery rate (FDR) at the α = 0.05 level. Regional volumes were also compared across groups by MANOVA. Unpaired t-tests were used to compare differences in scan parameters, V~TCER~ and f~1~ between the two groups.

The correlation of D~1~ receptor availability and cocaine seeking behavior was analyzed by linear regression between BP~p~ and BP~ND~ and the choice for cocaine. For this analysis, the VST was chosen a priori for correlation with the choice for a 6 mg dose of cocaine. Exploratory analysis was performed to examine the correlation between receptor availability and positive effects of cocaine. A two tailed probability value of p \< 0.05 was chosen as the level of significance for these analyses.

Results {#S13}
=======

Group comparison {#S14}
----------------

Twenty-five CD subjects and twenty-three HC subjects were enrolled in this study. The group demographics are shown in [table 1](#T1){ref-type="table"}. Of the 25 CD subjects, one completed the PET scans and the self-administration sample session but not the choice session due to a scheduling conflict. The CD subjects had been smoking crack cocaine an average of 16.4 ± 4.5 years and spent an average of \$264 ± \$118/week over the last six months.

PET scan parameters {#S15}
-------------------

There was no significant difference between the two groups with respect to injected dose (HC: 14.3 ± 3.4 mCi, CD: 13.1 ± 4.2 mCi; p = 0.38) or specific activity (HC: 1007 ± 456 Ci/mmoles, CD: 969 ± 454 Ci/mmoles; p = 0.77). Plasma clearance did not differ between groups (HC: 83.6 ± 31.2 L h^-1^; CD: 93.0 ± 27.4 L h^-1^, p= 0.28) nor did the plasma free fraction (f~1~) (HC: 0.88 ± 0.41%; CD: 0.86 ± 0.36%, p = 0.89). The volume of distribution of the cerebellum (VT~CER~) was 2.17 ± 0.49 mL g^-1^ in HC subjects and 2.32 ± 0.46 mL g^-1^ in CD subjects (p = 0.28).

The volumes of the regions of interest for each group were analyzed with a MANOVA, which did not show a significant volume difference between groups (Hotelling\'s trace, p = 0.102). Two regions did have low p values when unpaired t-tests were applied on individual regions (OFC, p = 0.013 and TC, p = 0.015) but these did not survive multiple comparison correction by the FDR criterion.

D~1~ receptor availability {#S16}
--------------------------

Representative PET scans are shown in [figure 1](#F1){ref-type="fig"}. There was no significant difference between groups for BP~p~ and BP~ND~ (MANOVA, p = 0.35 for BP~p~ and p = 0.219 for BP~ND~). The values are provided in [table 2](#T2){ref-type="table"}. Unpaired t-tests on individual regions did not reach significance after correction for multiple comparisons according to the FDR criterion. Although a decrease in BP~p~ and BP~ND~ was seen in the ventral striatum in the cocaine dependent subjects compared to healthy controls, this difference did not reach significance.

Cocaine self-administration session results {#S17}
-------------------------------------------

In the sample sessions, the positive effects of cocaine varied with the dose. The AUC of the positive effects cluster of the 12 mg dose (314 ± 622) was higher than that of the 0 mg (135 ± 441) and 6 mg doses (151 ± 419) (p \< 0.05 for both comparisons). No significant difference was seen between the positive effects of the 0 and 6 mg doses (p = 0.30). Since only the 12 mg dose elicited positive subjective effects different from placebo, the effects of the 12 mg dose were selected for comparison with the PET scan data.

In the choice sessions, subjects could choose cocaine 0 to 5 times. The 0 mg dose was chosen an average of 0.33 ± 1.05 times, the 6 mg dose was chosen 1.58 ± 1.67 times, and the 12 mg dose was chosen 3.21 ± 1.61 times. The 12 mg dose was chosen more frequently than both the 0 mg and 6 mg dose (p \< 0.001 for both cases) and the 6 mg dose was also chosen more frequently than the 0 mg dose (p = 0.002). The rationale for using low doses of cocaine in the self-administration sessions was to ensure enough variability between subjects to allow comparison with the PET data. The coefficient of variation (%CV) was higher for the 6 mg dose (1.05) compared to the 12 mg (0.50). Therefore, the 6 mg was chosen a priori for comparison with the PET data.

Relationship between PET data and cocaine self-administration {#S18}
-------------------------------------------------------------

As shown in [figure 2](#F2){ref-type="fig"}, there was a significant negative correlation between D~1~ receptor BP~ND~ in the ventral striatum and the choice for cocaine (r = -0.47, p = 0.02, corrected for age), such that the cocaine dependent subjects with the lowest values for BP~ND~ were more likely to choose a 6 mg dose of smoked cocaine. Exploratory analysis with the other striatal ROIs failed to show significant association between choice and BP~ND~ (preDCA: r = 0.27, p = 0.21, preDPU: r = 0.19, p = 0.37, postCA: r = 0.12, p = 0.60, postPU: r = 0.05, p = 0.83, STR: r = 0.23, p = 0.30). No correlation was seen between BP~P~ in the ventral striatum, or any other ROI, and the choice to self-administer 6 mg cocaine. No correlation was seen between BP~P~ or BP~ND~ in any brain region and the choice to self-administer the 12 mg dose of cocaine. No correlation was seen between BP~P~ or BP~ND~ and the positive effects of the 12 mg dose of cocaine.

A significant negative correlation was also seen between BP~ND~ in the VST and years of cocaine use (r = -0.59, p = 0.01, corrected for age). Exploratory analysis failed to detect significant correlation between years of use and BP~ND~ or BP~P~ in any other striatal region.

Discussion {#S19}
==========

The results of this study do not support the hypothesis that D~1~ receptor availability, measured with PET and the radiotracer \[^11^C\]NNC 112, is reduced in the ventral striatum of cocaine dependent subjects compared to healthy controls. However, within the cocaine dependent subjects, low D~1~ receptor availability in the ventral striatum may be associated with the choice to self-administer cocaine. In this study, an association was seen between \[^11^C\]NNC 112 BP~ND~ (although not BP~P~) in the ventral striatum and the choice to self-administer the 6 mg dose of smoked cocaine.

D~1~ receptor availability and cocaine dependence {#S20}
-------------------------------------------------

In this dataset, we found no significant difference in \[^11^C\]NNC 112 BP~P~ or BP~ND~ in each of the regions of interest investigated. While this finding is in agreement with a human postmortem study reporting that striatal D~1~ receptor mRNA is unchanged following chronic cocaine exposure ([@R34]), pre-clinical studies investigating this effect have not been consistent. Previous studies in rodents have reported both an increase and decrease in striatal D~1~ receptors following cocaine exposure ([@R28]; [@R30]; [@R51]). To our knowledge, only one previous study has used PET imaging and the radiotracer \[^11^C\]SCH23390 to measure changes D~1~ receptor binding, and this study showed a significant decrease in BP~ND~ in rodents following at least 7 days of cocaine administration ([@R50]).

Studies in non-human primates have also shown conflicting results. Two studies in rhesus monkeys have reported a decrease in D~1~ receptor binding following cocaine exposure. Farfel et al reported that 14 days of experimenter-administered cocaine followed by 14 days withdrawal resulted in a decrease in D~1~ receptor density in the caudate, with no change in the nucleus accumbens ([@R16]). A subsequent study used \[^3^H\]SCH23390 to label the D~1~ receptor, and reported decreased binding in the nucleus acumens in rhesus monkeys who self-administered cocaine for 18-22 months ([@R37]). However, two other studies in rhesus monkeys have used \[^3^H\]SCH23390 to label the D~1~ receptor and shown increases in receptor binding following cocaine self-administration. The study by Nader et al ([@R39]) showed that 100 days of cocaine self-administration increased D~1~ receptor binding in the dorsolateral and ventromedial caudate and putamen in addition to the shell of the nucleus accumbens. More recently, Beveridge et al ([@R7]) used the same paradigm and showed similar results, but also showed that D~1~ receptor binding returned to baseline following 90 days of abstinence. Overall, these data in animals suggest that D~1~ receptor availability may vary with respect to the duration of cocaine exposure and abstinence, and a recent study in rodents also showed that D~1~ receptor binding varies with the time of withdrawal ([@R6]). In the present study, the cocaine dependent particpants had a long history of cocaine exposure, such that the design of this study is more in line with that of Moore et al ([@R37]). Although we saw a decrease in striatal D~1~ receptor availability, it was not significant. However, it is possible that D~1~ receptor BP might have been lower had we performed the PET scans following a shorter duration of abstinence. In other words, it is possible that the cocaine subjects had lower D~1~ receptor BP prior to the 14 days ob abstinenece, and in this study, they were scanned as D~1~ receptor density was returning to baseline.

Another potential issue that must be considered in this study is that of cigarette smoking. A previous PET study using the radiotracer \[^11^C\]NNC 112 reported a decrease in D~1~ receptor availability in the ventral striatum of cigarette smokers compared to non-smokers ([@R11]). In the present study, subjects were matched for smoking, so it is unlikely that smoking status was a source of artifact. Nevertheless, we performed a 2 way ANOVA with group (HC and CD) and smoking status (nonsmokers and ex-smokers pooled) as treatments. In fact VST BP~ND~ was higher among smokers than non-smokers at trend level (smokers = 2.30 ± 0.46, non-smokers = 2.04 ± 0.46, p = 0.078), though the group by smoker interaction was not significant (p = 0.613).

It is also possible that this study lacked the power to detect a between group difference. If the variance observed in this study is taken as an estimate of population variance, then the between group difference in BP~ND~ required to reach significance would be about 17% (for α = 0.05 critical level and 1 - β = 0.8 power). However, we saw only a non-significant decrease of 8% in BP~ND~ in the ventral striatum, and less of a difference in the other striatal regions.

D~1~ receptor transmission and cocaine dependence {#S21}
-------------------------------------------------

Previous pre-clinical studies have shown conflicting results with respect to the effects of D~1~ agonist and antagonist administration on the behavioral effects of cocaine administration. Previous studies have shown that D~1~ agonists reduce cocaine-seeking behavior ([@R12]; [@R35]; [@R45]), decrease cocaine self-administration ([@R5]; [@R9]), and increased the latency for cue-induced cocaine-seeking behavior ([@R2]). In addition, a recent study in D~1~ knock-out mice showed that the D~1~ receptor is crucial for mediating the reinforcing effects of cocaine ([@R10]). Similar results have been reported with non-human primates ([@R25]; [@R26]; [@R38]; [@R41]). However, the opposite effect has also been shown, in which D~1~ antagonist administration attenuates priming- and cue-induced cocaine-seeking behavior ([@R2]; [@R5]; [@R26]; [@R27]; [@R29]), blocks cocaine-induced conditioned place preference ([@R4]; [@R40]), and blocks the reinstatement of cocaine self-administration ([@R3]; [@R42]). In short, some studies show that D~1~ receptor activation may inhibit cocaine-seeking behavior, while other studies suggest that D~1~ receptor blockade may have a more beneficial effect.

Studies in humans, while limited, suggest that stimulation of D~1~ receptors in humans may reduce the reinforcing effects of cocaine, whereas blockade of the D~1~ receptor enhances the reinforcing effects. In a study of cocaine-dependent participants, the D~1~ antagonist SCH 39166 has been shown to increase both cocaine self-administration in addition to the subjective measures of "High," "Stimulated," and "Good Drug Effect" ([@R22]). Alternatively, the administration of ABT-431, a full agonist at the D~1~ receptor, to cocaine dependent subjects significantly decreased the positive subjective effects of cocaine ([@R21]). ABT-431 did not significantly affect cocaine self-administration, although its dosage is limited in humans due to side effects.

D1 receptor availability and the addictive phenotype {#S22}
----------------------------------------------------

In the present study, low D~1~ receptor availability correlated with both the choice to self-administer low dose cocaine and years of cocaine use. This finding suggests that low D~1~ receptor binding potential may be indicative of a particular phenotype. Cocaine dependent subjects with low D~1~ receptor binding may have a more severe addiction, such that they are more vulnerable to the effects of a priming dose of cocaine and self-administer more cocaine. This is in agreement with the recent study investigating the "addictive phenotype" in rodents ([@R14]). In this study, rodents trained to self-administer cocaine were characterized as having higher vs lower preferred levels of cocaine intake. The rodents with higher levels of cocaine intake were found to be less sensitive to the effects of D~1~ receptor agonist in reducing cocaine-induced reinstatement of cocaine seeking behavior ([@R14]). Notably, chronic cocaine exposure produces a persistent upregulation of cAMP-PKA pathways in the nucleus accumbens, which then weakens further D~1~ receptor signaling and down-regulates D~1~ receptor expression ([@R43]; [@R52]). Thus, we had hypothesized that cocaine dependence would be associated with a decrease in D~1~ receptor binding compared to healthy controls. While we did see a decrease in \[^11^C\]NNC 112 BP~ND~ in the limbic striatum, it was not significant (BP~ND~ was 2.32 in HC vs 2.13 in CD, p = 0.17, two group t-test, not corrected for multiple observations). However, the possibility remains that cocaine dependent subjects who chose to self-administer higher doses of cocaine may represent a phenotype in which D~1~ receptor binding is decreased in the limbic striatum. In order to test this hypothesis, we performed a post-hoc analysis in which the cocaine dependent subjects were divided into two groups: those who self-administered 0 or 1 dose of cocaine and those who self-administered 2 to 5 doses of cocaine. This analysis showed that the low (0 to 1) self-administration group had a higher D~1~ receptor BP~ND~ compared to those who self-administered 2 to 5 doses of cocaine (BP~ND~ was 2.32 in low self-administration group vs 2.13 in the high self-administration group, p = 0.04). This finding is consistent with the hypothesis that a phenotype of cocaine dependent subjects with low D~1~ receptor binding in the ventral striatum may represent a group with greater vulnerability to the reinforcing effects of cocaine.

Study Limitations {#S23}
-----------------

The limitations of this study include the lack of a significant correlation between BP~P~ and the choice to self-administer cocaine, the lack of a correlation between the choice to administer the 12mg dose of cocaine and BP~ND,~ and the lack of selectivity of \[^11^C\]NNC 112 for D~1~ versus serotonin type 2A receptor (5-HT~2A~) receptors ([@R48]). While there was evidence of a negative correlation between \[^11^C\]NNC 112 BP^P^ and the choice to self-administer the 6 mg dose of cocaine, this was not significant (r = -0.30, p = 0.19). Thus, it is possible that this study lacked the power to detect a correlation with BP~P~, given that this outcome measure has a higher variability than BP~ND~. The lack of a correlation between the 12 mg dose of cocaine and \[^11^C\]NNC 112 binding (both BP~P~ and BP~ND~) may be due to the lower coefficient of variation seen with the 12 mg self-administration sessions. The majority of subjects (17 of 24) self-administered 3 or more doses of the 12 mg dose in the cocaine self-administration sessions, so that there may have been insufficient variability to detect a correlation. Lastly, while approximately 30% of the binding of \[^11^C\]NNC 112 can be attributed to the 5-HT~2A~ receptor in the cortex, there does not appear to be any significant binding to the 5-HT~2A~ receptor in the striatum ([@R48]). The same is also true for \[^11^C\]SCH23390, so that the difference seen between this study and that of Tsukada et al ([@R50]) cannot be attributed to this issue.
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![\[^11^C\]NNC 112 distribution in a healthy control subject (left) and a cocaine dependent subject (right). Both images are the mean of data acquired from 0-90 minutes and the image display was corrected for injected dose. The selected images include the striatum rostral to the anterior commissure. No significant difference in D~1~ receptor availability was seen between the two groups.](nihms-81354-f0001){#F1}

![Correlation between \[^11^C\]NNC 112 BP~ND~ in the VST (x axis) and the choice to self-administer 6 mg doses of cocaine (y axis, range 0-5). A significant correlation was found between D~1~ receptor availability and the choice to self-administer cocaine over an alternative reinforcer (voucher worth \$5) (r = -0.47, p = 0.02, corrected for age).](nihms-81354-f0002){#F2}

###### 

Group demographics

  Parameter                                                    HC           CD           p
  ------------------------------------------------------------ ------------ ------------ ------
  n                                                            23           25           \-
  Age (mean ± SD, years)                                       38 ± 4       40 ± 4       0.33
  Gender (Male/Female)                                         19M/6F       19M/4F       \-
  Ethnicity (Afro-American/Hispanic/ Caucasian not Hispanic)   16AA/4H/5C   12AA/5H/6C   0.61
  Smoking status (Yes/Ex/No)                                   16Y/3E/4N    19Y/3E/3N    0.53
  Mean ± cigarettes per day in smokers                         11 ± 8       11 ± 4       0.82

Abbreviations: HC: healthy control subjects; CD: cocaine dependent subjects.

###### 

\[^11^C\]NNC 112 binding potential (BP~P~, mL g^-1^) and specific to nonspecific partition coefficient (BP~ND~, unitless)

  --------------------------------------------------------------------------------
                Region of interest         BP~P~     BP~ND~              
  ------------- -------------------------- --------- --------- --------- ---------
  Striatum      Ventral striatum           5.03 ±\   4.89 ±\   2.32 ±\   2.13 ±\
                                           1.61      1.11      0.51      0.43

                Pre-commissural dorsal\    6.02 ±\   6.19 ±\   2.78 ±\   2.67 ±\
                caudate                    1.57      1.32      0.43      0.33

                Post-commissural\          4.38 ±\   4.81 ±\   2.06 ±\   2.02 ±\
                dorsal caudate             1.38      1.36      0.37      0.46

                Pre-commissural dorsal\    6.69 ±\   6.70 ±\   3.08 ±\   2.91 ±\
                putamen                    1.76      1.28      0.43      0.33

                Post-commissural\          6.15 ±\   6.45 ±\   2.82 ±\   2.80 ±\
                dorsal putamen             1.81      1.26      0.46      0.32

  Subcortical   Amygdala                   1.08 ±\   1.18 ±\   0.51 ±\   0.51 ±\
                                           026       0.34      0.11      0.12

                Hippocampus                0.66 ±\   0.63 ±\   0.31 ±\   0.27 ±\
                                           0.26      0.20      0.11      0.07

  Cortical      Dorsolateral prefrontal\   1.18 ±\   1.10 ±\   0.55 ±\   0.47 ±\
                cortex                     0.37      0.30      0.12      0.09

                Medial prefrontal\         1.41 ±\   1.35 ±\   0.65 ±\   0.59 ±\
                cortex                     0.40      0.27      0.13      0.08

                Orbitofrontal cortex       1.00 ±\   0.97 ±\   0.47 ±\   0.42 ±\
                                           0.35      0.37      0.15      0.13

                Anterior cingulate         1.54 ±\   1.57 ±\   0.71 ±\   0.68 ±\
                                           0.43      0.38      0.13      0.12

                Temporal cortex            1.25 ±\   1.27 ±\   0.58 ±\   0.55 ±\
                                           0.33      0.30      0.10      0.09

                Parietal cortex            1.24 ±\   1.14 ±\   0.57 ±\   0.49 ±\
                                           0.38      0.29      0.13      0.08

                Occipital cortex           1.24 ±\   1.22 ±\   0.58 ±\   0.53 ±\
                                           0.39      0.28      0.13      0.08
  --------------------------------------------------------------------------------

Values are Mean ± SD. No significant differences were seen between the two groups.
